The health benefits of wine

Annual Review of Nutrition

Volumn 20, Issue , 2000, Pages 561-593

  German, J B ^a   Walzem, R L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Chronic disease; Moderate ethanol intakes; Nutrition; Oxidation; Polyphenols

Indexed keywords

ALCOHOL; LIPOPROTEIN;

ALCOHOL CONSUMPTION; CARDIOVASCULAR DISEASE; CELL METABOLISM; CHEMICAL COMPOSITION; HUMAN; LIPOPROTEIN METABOLISM; NONHUMAN; NUTRITIONAL VALUE; OXIDATION; PRIORITY JOURNAL; REVIEW; WINE;

ALCOHOL DRINKING; CONFOUNDING FACTORS (EPIDEMIOLOGY); CORONARY DISEASE; DIABETES MELLITUS; ETHANOL; HUMANS; LIPOPROTEINS; NEOPLASMS; WINE;

EID: 0033826684     PISSN: 01999885     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.nutr.20.1.561     Document Type: Review

References (209)

1. Role of alcohol and tobacco in the aetiology of head and neck cancer: A case-control study in the Doubs region of France
2. Nitric oxide production and endothelium-dependent vasorelaxation induced by wine polyphenols in rat aorta
3. Natural dietary polyphenolic compounds cause endothelium-dependent vasorelaxation in rat thoracic aorta
4. Polyphenolic flavonoids inhibit macrophage-mediated oxidation of LDL and attenuate atherogenesis
5. Red wine consumption inhibits LDL oxidation and aggregation in humans and in atherosclerotic mice
6. Human serum paraoxonase (PON 1) is inactivated by oxidized low-density lipoprotein and preserved by antioxidants
7. Alcohol intake impairs glucose counterregulation during acute insulin-induced hypoglycemia in IDDM patients: Evidence for a critical role of free fatty acids
8. Beneficial effects of alcohol withdrawal on LDL particle size distribution and oxidative susceptibility in subjects with alcohol-induced hypertriglyceridemia
9. Protective effects of grape seed proanthocyanidins and selected antioxidants against TPA-induced hepatic and brain lipid peroxidation and DNA fragmentation, and peritoneal
10. Role of oxidative stress in development of complications in diabetes
11. (+)-Catechin in human plasma following ingestion of a single serving of reconstituted red wine
12. Plasma and tissue resveratrol concentrations and pharmacological activity
13. Plasma, urine and tissue levels of trans- and cis-resveratrol (3,4',5-trihydroxystilbene) after short-term or prolonged administration of red wine to rats
14. Gas chromatographic analysis of resveratrol in plasma, lipoproteins and cells after in vitro incubations
15. Polyphenols produced during red wine ageing
16. Lipoprotein metabolism in the macrophage: Implications for cholesterol deposition in atherosclerosis
17. Lipid advanced glycosylation. Pathway for lipid oxidation in vivo
18. Nonalcoholic compounds of wine: The phytoestrogen resveratrol and red wine consumption during menopause
19. Moderate alcohol consumption and risk for angina pectoris or myocardial infarction in U.S. male physicians
20. Serum antioxidant capacity is increased by consumption of strawberries, spinach, red wine or vitamin C in elderly women
21. Levels of flavan-3-ols in French wines
22. Report of the expert panel on population strategies for blood cholesterol reduction. A statement from the NCEP, NHLBI, NIH
23. Alcohol and blood lipids. The cooperative lipoprotein phenotyping study
24. Susceptibility of small, dense, low-density lipoproteins to oxidative modification in subjects with the atherogenic lipoprotein phenotype, pattern
25. Effect of red wine on endothelium-dependent relaxation in rabbits
26. Do known cardiovascular risk factors mediate the effect of alcohol on cardiovascular disease?
27. The effect of red wine on experimental atherosclerosis: Lipid-independent protection
28. Effect of concentrated red grape juice consumption on serum antioxidant capacity and low-density lipoprotein oxidation
29. Hard liquor drinking is associated with higher risk of cancer of the oral cavity and pharynx than wine drinking: A case-control study in Uruguay
30. Flavonoids inhibit the oxidative modification of low density lipoproteins by macrophages
31. Beverage effects on patterns of alcohol consumption
32. Administration of wine and grape juice inhibits in vivo platelet activity and thrombosis in stenosed canine coronary arteries
33. Catechin is present as metabolites in human plasma after consumption of red wine
34. Cyclooxygenase in biology and disease
35. Phytoalexin resveratrol (3-4'-5-trihydroxystilbene) modulates granulocyte and monocyte endothelial adhesion
36. Activity in vitro of resveratrol on granulocyte and monocyte adhesion to endothelium
37. Molecular physiology of reverse cholesterol transport
38. Vasorelaxation, endothelium, and wine
39. Endothelium-dependent vasorelaxing activity of wine and other grape products
40. Effects of red and white wine on endothelium-dependent vasorelaxation of rat aorta and human coronary arteries
41. Inhibition of platelet activity with red wine and grape products
42. Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine
43. Inhibition of human LDL oxidation by resveratrol
44. Principal phenolic phytochemicals in selected California wines and their antioxidant activitiy in inhibiting oxidation of human low-density lipoproteins
45. Dietary flavonoids reduce lipid peroxidation in rats fed polyunsaturated or monounsaturated fat diets
46. Lifetime alcohol consumption and risk of breast cancer
47. A cohort study of alcohol consumption and risk of breast cancer
48. Effect of probucol treatment on gene expression of VCAM-1, MCP-1, and M-CSF in the aortic wall of LDL receptor-deficient rabbits during early atherogenesis
49. Type of alcoholic beverage and risk of myocardial infarction
50. Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor
51. Wine phenolics and targets of chronic diseases
52. Antioxidant activity of different phenolic fractions separated from an Italian red wine
53. Biology of the vessel wall: Endothelium
54. Concentrations of selected polyphenols in white commercial wines
55. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition
56. Moderate red wine consumption in healthy volunteers reduced plasma clearance of apolipoprotein AII
57. Wine and mortality
58. Population based cohort study of the association between alcohol intake and cancer of the upper digestive tract
59. Mortality associated with moderate intakes of wine, beer, or spirits
60. Alcohol consumption and risk of coronary heart disease. Studies suggest that wine has additional effect to that of ethanol
61. Mortality differences associated with moderate consumption of beer, wine and spirits
62. The metabolism of flavonoid compounds in mammals
63. Alcohol: Medical and nutritional effects
64. Alcohol, height, and adiposity in relation to estrogen and prolactin levels in postmenopausal women
65. Reduction in the concentration and activity of plasma cholesteryl ester transfer protein by alcohol
66. Reduced progression of atherosclerosis in apolipoprotein E-deficient mice following consumption of red wine, or its polyphenols quercetin or catechin, is associated with reduced susceptibility of LDL to oxidation and aggregation
67. Moderate doses of alcoholic beverages with dinner and postprandial high density lipoprotein composition
68. Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: Recognition by receptors for acetylated low density lipoproteins
69. Polydisperse low-density lipoproteins in hyperalphalipoproteinemic chronic alcohol drinkers in association with marked reduction of cholesteryl ester transfer protein activity
70. Low-density lipoproteins in hyperalphalipoproteinemic heavy alcohol drinkers have reduced affinity for the low-density lipoprotein receptor
71. Absorption, metabolism, and bioavailability of flavonoids
72. Absorption of dietary quercetin glycosides and quercetin in healthy ileostomy volunteers
73. Absorption and disposition kinetics of the dietary antioxidant quercetin in man
74. Relative bioavailability of the antioxidant flavonoid quercetin from various foods in man
75. Diabetes mellitus
76. Hydroxyl radical production and autooxidative glycosylation
77. Ethanol stimulates apo A-1 secretion in human hepatocytes: A possible mechanism underlying the cardioprotective effect of ethanol
78. Relaxant effect of trans-resveratrol on isolated porcine coronary arteries
79. Alcohol and other beverage use and prostate cancer risk among Canadian men
80. Detoxication: Conjugation and hydrolysis
81. 14C-labeled condensed tannins and related sorghum phenolics in chickens
82. Role of diabetes in cardiac disease: Conclusions from population studies. The Framingham Study
83. Oxidized low density lipoprotein: Atherogenic and proinflammatory characteristics during macrophage foam cell formation: An inhibitory role for nutritional antioxidants and serum paraoxonase
84. Red wine and fractionated phenolic compounds prepared from red wine inhibit low density lipoprotein oxidation in vitro
85. Possible mechanisms for the protective role of antioxidant in wine and plant foods
86. Alcoholic beverage choice and risk of coronary artery disease mortality: Do red wine drinkers fare best?
87. Red wine, white wine, liquor, beer, and risk for coronary artery disease hospitalization
88. Type I macrophage scavenger receptor contains alpha-helical and collagen-like coiled coils
89. Alcohol with a meal has no adverse effects on postprandial glucose homeostasis in diabetic patients
90. Identification of multiple subclasses of plasma low density lipoproteins in normal humans
91. Lipoproteins and blood pressure as biological pathways for effect of moderate alcohol consumption on coronary heart disease
92. Bioavailability of red wine anthocyanins as detected in human urine
93. The procyanidins of white grapes and wine
94. Dietary flavonols protect diabetic human lymphocytes against oxidative damage to DNA
95. A plasma polyphenols and antioxidants, oxidative DNA damage and endothelial function in a diet and wine intervention study in humans
96. Atherogenesis and inflammation
97. Alcoholic beverage consumption in relation to risk of breast cancer: Meta-analysis and review
98. Risk of breast cancer in relation to lifetime alcohol consumption
99. Quercetin is recovered in human plasma as conjugated derivatives which retain antioxidant properties
100. Quercetin metabolites in plasma of rats fed diets containing rutin or quercetin
101. Quercetin inhibits LPS-induced nitric oxide and tumor necrosis factor-alpha production in murine macrophages
102. Anthocyanins in grapes and grape products
103. Change in LDL particle size is associated with change in plasma triglyceride concentration
104. Alcohol-induced generation of lipid peroxidation products in humans
105. Alcohol consumption and ischemic heart disease mortality in Sweden
106. Effect of plant flavonoids on immune and inflammatory cell function
107. Associations of alcohol consumption with plasma high density lipoprotein cholesterol and its major subfractions: The Caerphilly and Speedwell Collaborative Heart Disease Studies
108. Inhibition of human low-density lipoprotein oxidation by flavonoids in red wine and grape juice
109. Extract of wine phenolics improves aortic biomechanical properties in stroke-prone spontaneously hypertensive rats (SHRSP)
110. Moderate alcohol consumption and coronary artery disease: A review
111. Gallates inhibit cytokine-induced nuclear translocation of NF-κB and expression of leukocyte adhesion molecules in vascular endothelial cells
112. The Yin and Yang of oxidation in the development of the fatty streak
113. Wine and migraine: Compatibility or incompatibility?
114. Consumption of red wine polyphenols reduces the susceptibility of low-density lipoproteins to oxidation in vivo
115. Effects of alcohol on lipoprotein lipase, hepatic lipase, cholesteryl ester transfer protein, and lecithin: Cholesterol acyltransferase in high-density lipoprotein cholesterol elevation
116. Moderate wine consumption is associated with decreased odds of developing age-related macular degeneration in NHANES-1
117. Wine consumption and dementia in the elderly: A prospective community study in the Bordeaux area
118. Grape juice but not orange or grapefruit juice inhibits platelet activity in dogs and monkeys
119. Wines and grape juices as modulators of platelet aggregation in healthy human subjects
120. The polyphenolic content of fruit and vegetables and their antioxidant activities. What does a serving constitute?
121. The identification of flavonoids as glycosides in human plasma
122. Variation in the quercetin content in different colored onions
123. Inhibition of endothelial cell-mediated oxidation of LDL by green tea antioxidants
124. Inhibition of endothelial cell-induced oxidation of LDL by rosemary and plant phenolic antioxidants
125. Effects of moderate consumption of red wine on platelet aggregation and haemostatic variables in healthy volunteers
126. Resveratrol, a polyphenolic compound found in wine, inhibits tissue factor expression in vascular cells: A possible mechanism for the cardiovascular benefits associated with moderate consumption of wine
127. Accumulation of (-)-epicatechin metabolites in rat plasma after oral administration and distribution of conjugation enzymes in rat tissues
128. Alcohol intake and the risk of lung cancer: Influence of type of alcoholic beverage
129. Epidemiology of transitional cell carcinoma of the bladder: Profile of an urban population in the south-west of England
130. Moderate alcohol consumption and estrogen levels in postmenopausal women: A review
131. Diabetes and atherosclerosis: An epidemiologic view
132. Role of alcoholic beverages in essential hypertensive patients
133. A controlled trial of the effects of pattern of alcohol intake on serum lipid levels in regular drinkers
134. Role of insulin resistance in human disease
135. Dietary and pharmacologic regimens to reduce lipid peroxidation in non-insulin-dependent diabetes mellitus
136. Modulation of platelet activation by cacao or red wine polyphenols in vitro
137. Wine, alcohol, platelets, and the French paradox for coronary heart disease
138. Alcohol and mortality in middle-aged men from eastern France
139. Effects of alcohol on platelet functions
140. Measurement of the antioxidant status of dietary constituents, low density lipoproteins and plasma
141. The relative antioxidant activities of plant-derived polyphenolic flavonoids
142. Plasma kinetics in man of epiatechin from black chocolate
143. Alcohol consumption and coronary heart disease: Good habits may be more important than just good wine
144. Alcohol in the Mediterranean diet
145. Relation between intake of flavonoids and risk for coronary heart disease in male health professionals
146. Review of moderate alcohol consumption and reduced risk of coronary heart disease: Is the effect due to beer, wine, or spirits?
147. A standard red wine: Monomeric phenolic analysis of commercial cabernet sauvignon wines
148. Atherosclerosis - An inflammatory disease
149. Cell cholesterol efflux: Integration of old and new observations provides new insights
150. Wine and polyphenols related to platelet aggregation and atherothrombosis
151. Platelet rebound effect of alcohol withdrawal and wine drinking in rats. Relation to tannins and lipid peroxidation
152. Contents of resveratrol, piceid, and their isomers in commercially available wines made from grapes cultivated in Japan
153. Interaction between the carboxylterminal heparin-binding domain of fibronectin and (-)-epigallocatechin gallate
154. Evidence for the interaction between (-)-epigallocatechin gallate and human plasma proteins fibronectin, fibrinogen, and histidine-rich glycoprotein
155. Differential effects of small and large molecular weight wine phytochemicals on endothelial cells eicosanoid release
156. Potential effects of flavonoids on the etiology of vascular disease
157. Endothelial cell basal PGI, 2 release is stimulated by wine in vitro: One mechanism that may mediate the vasoprotective effects of wine
158. Flavour composition of wines: A review
159. Alcohol-free red wine enhances plasma antioxidant capacity in humans
160. Effect of red wine on coronary flow-velocity reserve
161. Antioxidant functions of vitamins. Vitamins E and C, beta-carotene, and other carotenoids
162. De novo lipogenesis, lipid kinetics, and whole-body lipid balances in humans after acute alcohol consumption
163. Plant phenolics
164. The phenolic cinnamates of white grapes and wine
165. White wine phenolics: Varietal and processing differences as shown by HPLC
166. Classification of French red wines according to their geographical origin by the use of multivariate analyses
167. Resveratrol: A molecule whose time has come? And gone?
168. Reverse cholesterol transport and atherosclerosis regression
169. The small intestine can both absorb and glucuronidate luminal flavonoids
170. Factors associated with cardiac mortality in developed countries with particular reference to the consumption of wine
171. Purple grape juice improves endothelial function and reduces the susceptibility of LDL cholesterol to oxidation in patients with coronary artery disease
172. Lipoproteins, lipoprotein oxidation and atherogenesis
173. Lipoprotein receptors and cellular cholesterol metabolism
174. Disorders of lipoprotein metabolism
175. Sequence of alcohol-induced initial changes in plasma lipoproteins (VLDL and HDL) and lipolytic enzymes in humans
176. Alcohol-induced changes in serum lipoproteins and in their metabolism
177. Inhibition of in vitro human LDL oxidation by phenolic antioxidants from grapes and wines
178. Wine intake and diet in a random sample of 48763 Danish men and women
179. Intake of beer, wine, and spirits and risk of stroke: The Copenhagen City Heart Study
180. 5-year incidence of atherosclerotic vascular disease in relation to general risk factors, insulin level, and abnormalities in lipoprotein composition in non insulin-dependent diabetic and non-diabetic subjects
181. Bioavailability of catechins from tea: The effect of milk
182. Induction of net mass lipid transfer reactions in plasma by wine consumption with dinner
183. Cholesterol lowering and endothelial function
184. Effects of the wine polyphenolics quercetin and resveratrol on pro-inflammatory cytokine expression in RAW 264.7 macrophages
185. Older plasma lipoproteins are more susceptible to oxidation: A linking mechanism for the lipid and oxidation theories of atherosclerotic cardiovascular disease
186. Type of alcoholic drink and risk of major coronary heart disease events and all-cause mortality
187. Nutrition of grape phenolics
188. Protective effect of high density lipoprotein associated paraoxonase: Inhibition of the biological activity of minimally oxidized low density lipoprotein
189. Uptake and degradation of low density lipoprotein by swine arterial smooth muscle cells with inhibition of cholesterol biosynthesis
190. The response-to-retention hypothesis of early atherogenesis
191. Modulation of haemostatic function and prevention of experimental thrombosis by red wine in rats: A role for increased nitric oxide production
192. Is measuring serum antioxidant capacity clinically useful?
193. Alcohol consumption, diet, coronary risk factors, and prevalent coronary heart disease in men and women in the Scottish Heart health study
194. Dietary supplementation of grape polyphenols and chronic ethanol administration on LDL oxidation and platelet function in rats
195. Effect of dietary catechin and vitamin E on aortic fatty streak accumulation in hypercholesterolemic hamsters
196. Proanthocyanidin-rich extract from grape seeds attenuates the development of aortic atherosclerosis in cholesterol-fed rabbits
197. The ABCs of cholesterol efflux
198. Alcohol consumption and risk of breast cancer: The Framington Study revisited
199. Inhibition of catechol O-methyltransferase-catalyzed O-methylation of 2- and 4-hydroxyestradiol by quercetin. Possible role in estradiol-induced tumorigenesis
200. Determination of trans-resveratrol in human plasma by high-performance liquid chromatography